Ctrl Worx Watch List › Company

Glucotrack, Inc. (GCTK): material weakness open 1,763 days

By , Ctrl Worx™. Built from its own SEC filings. How the Clock works.

Glucotrack, Inc. reported ineffective internal control over financial reporting because of a material weakness in 5 filings since Mar 31, 2022. It stated one or more material weaknesses in 14 more SEC filings that gave no conclusion on whether that control is effective. The latest was its 10-Q for the period ended Jun 30, 2026.

Ctrl Worx Watch List™ status

On the Clock
4.8 yearsopen since Dec 31, 2021
10-Q, Aug 14, 2026latest filing that reports the weakness. Read it on SEC EDGAR
#416 of 1,250on the Clock by time open, tied with 41 other companies that share its start date. See the Clock

Still filing, and no annual report of its own says the weakness is fixed.

Checked against SEC EDGAR: Oct 29, 2026 · Entry #10870

Filings with a weakness19
First in our dataMar 31, 2022
AuditorCBIZ CPAs P.C.

Causes the company named

Segregation of duties · 15Accounting expertise and resources · 15ITGC: general · 15Complex or non-routine accounting · 8Entity-level and governance · 8Not described · 4

Insufficient IT controls, accounting personnel, and segregation of duties in financial reporting.

What the latest filing says

ation required to be included in periodic filings under the Exchange Act and that such information is not accumulated and communicated to management, including our principal executive officer, in a manner sufficient to allow timely decisions regarding required disclosure. The Company has identified material weaknesses in its internal control over financial reporting. As defined in Regulation 12b-2 under the Exchange Act, a “material weakness” is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented, or detected on a timely basis. The Company identified material weaknesses in its internal controls in the following areas: general IT controls; lack of sufficient accounting personnel and inadequate segregation of duties consistent with control objectives. None of these deficiencies resulted in a material misstatement to the Company’s interim and annual Consolidated Financial Statements for the periods ende [...]

From the controls section of the 10-Q filed Aug 14, 2026. Read the full filing on SEC EDGAR.

Company response: Glucotrack, Inc. can send a statement or a link to its remediation update to russell@ctrlworx.com. We post it here, unedited and dated.

Filings

FiledFormPeriodControlsCausesFiling
Aug 14, 202610-QJun 30, 2026Material weakness stated, no ICFR conclusionSegregation of duties; Accounting expertise and resources; ITGC: generalEDGAR
May 14, 202610-QMar 31, 2026Material weakness stated, no ICFR conclusionSegregation of duties; Accounting expertise and resources; ITGC: generalEDGAR
Mar 30, 202610-KDec 31, 2025Not effectiveSegregation of duties; Accounting expertise and resources; ITGC: generalEDGAR
Nov 13, 202510-QSep 30, 2025Material weakness stated, no ICFR conclusionSegregation of duties; Accounting expertise and resources; ITGC: generalEDGAR
Aug 14, 202510-QJun 30, 2025Material weakness stated, no ICFR conclusionSegregation of duties; Accounting expertise and resources; ITGC: generalEDGAR
May 14, 202510-QMar 31, 2025Material weakness stated, no ICFR conclusionSegregation of duties; Accounting expertise and resources; ITGC: generalEDGAR
Mar 31, 202510-KDec 31, 2024Not effectiveSegregation of duties; Accounting expertise and resources; ITGC: generalEDGAR
Nov 14, 202410-QSep 30, 2024Material weakness stated, no ICFR conclusionSegregation of duties; Accounting expertise and resources; Complex or non-routine accounting; ITGC: general; Entity-level and governanceEDGAR
Aug 13, 202410-QJun 30, 2024Material weakness stated, no ICFR conclusionSegregation of duties; Accounting expertise and resources; Complex or non-routine accounting; ITGC: general; Entity-level and governanceEDGAR
May 15, 202410-QMar 31, 2024Material weakness stated, no ICFR conclusionSegregation of duties; Accounting expertise and resources; Complex or non-routine accounting; ITGC: general; Entity-level and governanceEDGAR
Mar 28, 202410-KDec 31, 2023Not effectiveSegregation of duties; Accounting expertise and resources; Complex or non-routine accounting; ITGC: general; Entity-level and governanceEDGAR
Nov 14, 202310-QSep 30, 2023Material weakness stated, no ICFR conclusionSegregation of duties; Accounting expertise and resources; Complex or non-routine accounting; ITGC: general; Entity-level and governanceEDGAR
Aug 14, 202310-QJun 30, 2023Material weakness stated, no ICFR conclusionSegregation of duties; Accounting expertise and resources; Complex or non-routine accounting; ITGC: general; Entity-level and governanceEDGAR
May 12, 202310-QMar 31, 2023Material weakness stated, no ICFR conclusionNot describedEDGAR
Mar 31, 202310-KDec 31, 2022Not effectiveSegregation of duties; Accounting expertise and resources; Complex or non-routine accounting; ITGC: general; Entity-level and governanceEDGAR
Nov 14, 202210-QSep 30, 2022Material weakness stated, no ICFR conclusionNot describedEDGAR
Aug 15, 202210-QJun 30, 2022Material weakness stated, no ICFR conclusionNot describedEDGAR
May 16, 202210-QMar 31, 2022Material weakness stated, no ICFR conclusionNot describedEDGAR
Mar 31, 202210-KDec 31, 2021Not effectiveSegregation of duties; Accounting expertise and resources; Complex or non-routine accounting; ITGC: general; Entity-level and governanceEDGAR

Others on the Clock in the same industry

By SEC industry code: 3841, Surgical & Medical Instruments & Apparatus, then related codes.

Follow GCTK for free

Get an email when Glucotrack, Inc files a 10-K or 10-Q that reports a material weakness, or says its controls are effective again.

Want the next one the day it's filed?

MW Pro sends an alert the day a company you follow reports a material weakness or says it fixed one. Founding price $990 a year.

Join the MW Pro waitlistLook up any company in Controls Radar™

Watch List Weekly: new material weaknesses, fixes and the longest-running cases, every Monday.

One email to confirm, then one email each Monday. Every email has a one-click unsubscribe. Privacy policy

Based on public SEC filings. Causes are grouped into standard categories by Ctrl Worx. The filings are the authority. Ctrl Worx is not affiliated with Glucotrack, Inc. or the SEC. Not investment advice. Why you can rely on the Watch List.